ATP6V0CP2

Across TCGA pan-cancer cohorts, ATP6V0CP2 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated ATP6V0CP2 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher ATP6V0CP2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated ATP6V0CP2 expression acts as an unfavorable survival marker, although some lineages such as ESCA and BLCA show a favorable association.

MESO, ESCA, and KIRC are the cancer types where ATP6V0CP2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	DFS	Tertile	II,III,IV	0.158	0.419	.007	45	view →
ESCA	OS	Median	III,IV	0.705	0.440	.003	43	view →
KIRC	OS	Tertile	II,III,IV	0.350	0.574	.029	18	view →
UVM	OS	Tertile	All	0.629	0.928	.007	18	view →
BLCA	OS	Tertile	All	0.585	0.421	.012	18	view →
LUAD	DFS	Tertile	III,IV	0.279	0.645	.009	18	view →
STAD	OS	Tertile	III,IV	0.296	0.582	.015	15	view →
UCS	DFS	Tertile	IV	0.981	0.573	.025	12	view →
READ	OS	Tertile	IV	0.423	0.937	<.001	12	view →
SKCM	DFS	Tertile	IV	0.016	0.541	.008	9	view →
LIHC	OS	Tertile	II,III,IV	0.199	0.470	.048	9	view →
HNSC	DFS	Tertile	II,III,IV	0.656	0.271	.028	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

ATP6V0CP2–MESO (DFS)

Open the MESO breakdown →